Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
A mixture of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
EC number: 403-720-7 | CAS number: 117527-94-3 NOIR ORASOL 9342A; NOIR ORASOL RLI; ORASOL BLACK 9342A; ORASOL BLACK RLI; SAVINYL NOIR 2R
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 200 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Only screening study available.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No effects on fertility parameters were seen in a screening study (OECD 421, GLP) in rats.
Effects on developmental toxicity
Description of key information
A screening study in rats showed unexpected mortality in parental animals at 1000 and 500 mg/kg bw. Effects on the offspring (reduced number of pups born and body weight) were seen at 200 mg/kg bw. bw. The study followed OECD testing guideline 421 and was performed under GLP.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 50 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- A screening study in rats is available.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Three groups of 10 sexually mature males and 10 sexually mature females were dosed once daily orally, by gavage with the test item for two weeks before pairing, throughout the pairing period and until the day prior to necropsy for the males and Day 3 of lactation for females. Animals were dosed at 50, 200, or 1000 mg/kg bw/day. A similar group of males and females received the vehicle only, and served as controls. Since the dose of 1000 mg/kg bw/day caused mortality in 7 rats within one week, this group was terminated. A preliminary trial to see if animals would tolerate 500 mg/kg bw was discontinued after the first animal died at this dose group. Two further groups (12.5 mg/kg bw/day and an additional control group) were then added. A constant dose volume of 10 mL/kg bw was used and doses were adjusted according to the most recent body weight. Clinical observations, body weight, and food consumption were recorded at regular intervals throughout the study. After the two week pre-pairing dosing period, each female was paired with a male from the same group for up to four days (until mated). Vaginal smears were taken daily until sperm were found in the smear, whereupon the male was removed. Females were allowed to litter, and observations of total number of pups, pup sexes, pup body weights, clinical observations, and mortalities were made. Dams were killed on Day 4 of lactation with their litter, or on Day 25 of gestation if they had not littered. Males were killed after the females were necropsied. A macroscopic necropsy was performed for all animals and selected tissues from animals given 200 or 1000 mg/kg bw/day and initial control animals from Group 1 were examined microscopically
As result for the F0 Generation at 200 mg/kg bw/day black faeces, dark discoloured extremities and grey sperm plugs were observed. Body weight gains were slightly decreased in males. In females body weight gain was slightly impaired during the pre-pairing period, and moderately decreased during gestation, particularly during the last week. Body weights of females were decreased after birth and on Day 4 of lactation. Food consumption was slightly to moderately decreased in females during gestation and lactation. Haematological examinations revealed slightly decreased haemoglobin values in males and slightly decreased haematocrit values in both sexes. Additionally, decreased leucocyte counts, primarily of lymphocytes, were observed in females. Slightly decreased calcium concentrations were observed following clinical chemistry examinations in both sexes. At necropsy, the entire bodies of all animals were discoloured dark. There were no compound-related effects on mating performance, fertility, and gestation length. Rats dosed with 50 mg/kg bw/day also showed dark discoloured extremities, black faeces and grey copulation plugs. At necropsy, the entire bodies of all animals were discoloured dark. No other compound-related effects were observed. No compound-related effects were observed after administration at 12.5 mg/kg bw/day.
F1 Generation: At 200 mg/kg bw/day there was a significant increase in pup deaths up to lactation Day 4 and a decrease in both the mean number of pups born alive and the mean live birth index when compared with controls. All pups from dams given 200 mg/kg bw/day were abnormally dark in colour. Male as well as female pups had decreased group mean body weights on Day 1 and Day 4 of lactation accompanied by a decrease in group mean body weight gains. All pups from dams given 50 mg/kg bw/day were abnormally dark in colour when compared to control animals. No other compound-related effects were observed. No compound-related effects occurred at 12.5 mg/kg bw/day.
Justification for classification or non-classification
The screening study shows indication of developmental toxicity at doses also affected the parents by body weight loss. A final classification and labelling based on this screening study may not be feasible.
A more detailed discussion and submission of a CLH dossier is not performed because production of EC no. 403 -720 -7 has been ceased and the registration is set to inactive.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
